Neurological Disease History
c. 400 BCE, Hippocratic writings on age-related cognitive decline, ancient Greece
What we now recognize as Alzheimer's disease was long lumped together with the general concept of senility, regarded as an inevitable and unremarkable consequence of old age rather than as a distinct pathological process. The formal identification of the disease as a specific entity occurred only in the early twentieth century, following the application of new staining techniques to post-mortem brain tissue. The history of Alzheimer's disease is inseparable from the history of neuropathology as a scientific discipline.
Historical Narrative
Ancient and medieval physicians wrote extensively about the decline of mental faculties in old age, but they framed this deterioration as a natural feature of aging rather than a disease process deserving separate investigation. The Greek physician Pythagoras divided the human lifespan into stages, with the final stage — 'old age,' beginning around his estimate of sixty-three years — characterized by the gradual decay of all mental and physical functions. This fatalistic view, that the aging mind simply wore out like a piece of machinery, persisted across centuries and actively discouraged investigation.
During the Renaissance and into the Enlightenment, philosophers and physicians began distinguishing between ordinary age-related mental slowing and more dramatic presentations of confusion, disorientation, and memory failure in the elderly. The Scottish physician William Cullen in the eighteenth century included 'senile dementia' in his disease classifications, marking an early attempt to treat severe cognitive deterioration as a medical category rather than simply an expression of age. French physician Philippe Pinel and his student Jean-Étienne Dominique Esquirol further developed the clinical concept of dementia in the early nineteenth century, separating it from madness and categorizing it as a disorder of impaired reason.
The decisive transformation in understanding came from Germany in the early twentieth century. Alois Alzheimer, a Bavarian psychiatrist and neuropathologist working at the Royal Psychiatric Hospital in Munich under Emil Kraepelin, was presented in 1901 with a fifty-one-year-old patient named Auguste Deter who displayed severe memory problems and behavioral disturbances at an unusually young age. Alzheimer followed her case closely until her death in 1906, then applied the silver staining technique developed by Camillo Golgi to examine her brain tissue. He found two distinctive abnormalities: dense plaques in the spaces between nerve cells and tangled fibers within the cells themselves.
Alzheimer presented these findings at a lecture in Tübingen in November 1906 and published them in 1907. His supervisor Emil Kraepelin, the enormously influential psychiatrist who was constructing the modern nosological system of psychiatric disease classification, named the condition 'Alzheimer's disease' in the 1910 edition of his landmark psychiatric textbook, cementing the name in medical literature. For much of the twentieth century, Alzheimer's disease was considered rare because it was distinguished from the supposedly separate category of 'senile dementia,' which affected older patients. It was only in the 1970s and 1980s that researchers including Robert Katzman argued persuasively that the two were the same condition at different ages, dramatically reconceiving the scale of the disease and galvanizing research efforts worldwide.
Key Historical Figures
Historical narrative only — this page describes how Alzheimer's Disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.